The Fewer Transfusions, the Better for Newborns With Thrombocytopenia – ASH Clinical News
The Fewer Transfusions, the Better for Newborns With Thrombocytopenia – Bleeding Disorders, From the Blood Journals, Written in Blood – ASH Clinical News
Related Articles
AI-Assisted POCUS Could Help Identify Joint Bleeds in Hemophilia | ASH Clinical News | American Society of Hematology
Leah Lawrence is a freelance health writer and editor based in Delaware. Technology combining artificial intelligence (AI) and point-of-care ultrasonography (POCUS) could assist clinicians with…
Elderly Patients With BPDCN Respond Well to Venetoclax, Bortezomib, Dexamethasone Combination | ASH Clinical News | American Society of Hematology
Lara C. Pullen, PhD, is a freelance medical writer in Chicago, Illinois. Patients with the rare, aggressive hematologic malignancy blastic plasmacytoid dendritic cell neoplasm (BPDCN)…
Isatuximab Can Be Given as a Shorter Intravenous Infusion to Patients With Multiple Myeloma, New Trial Shows | ASH Clinical News | American Society of Hematology
Anna Azvolinsky is a science and health journalist based in New York City. A new clinical trial has found that a 30-minute intravenous (IV) infusion…
Relapse-Free Survival Progressively Shortens in Black Patients With Rituximab-Treated iTTP | ASH Clinical News | American Society of Hematology
Katie Robinson is a medical writer based in New York. In patients with relapsing immune thrombotic thrombocytopenic purpura (iTTP), successive rituximab treatment shortens relapse-free survival…
February 2025 | ASH Clinical News | American Society of Hematology
February 2025 | ASH Clinical News | American Society of Hematology February 2025 Thrown into Disarray The sudden withdrawal of voxelotor from the market left…
Anxiety, Depression Elevated in Patients with Histiocytic Neoplasms | ASH Clinical News | American Society of Hematology
Lara C. Pullen, PhD, is a freelance medical writer in Chicago, Illinois. While previous research has documented high levels of anxiety and depression in patients…
ASH Clinical News: February 2025 From the Desk Of…
Editor-in-Chief Aaron Gerds, MD, previews what’s to come in ASH Clinical News. Highlights of the February issue include a feature on the recent withdrawal of…
R/R ALL Treatment Receives FDA Approval | ASH Clinical News | American Society of Hematology
Obecabtagene autoleucel received approval from the U.S. Food and Drug Administration (FDA) for the treatment of relapsed or refractory (R/R) B-cell precursor acute lymphoblastic leukemia…
Oral Solution Imatinib Receives FDA Approval for Several Hematologic Diseases | ASH Clinical News | American Society of Hematology
Imatinib oral solution received U.S. Food and Drug Administration (FDA) approval for the treatment of chronic myeloid leukemia, acute lymphoblastic leukemia, and myelodysplastic syndromes/myeloproliferative neoplasms.…
January 2025 | ASH Clinical News | American Society of Hematology
January 2025 | ASH Clinical News | American Society of Hematology January 2025 Health Care Handcuffed? The overturning of the Chevron doctrine, a decades-old precedent,…